Treatment of osteoporsis, Paget's disease and other bone mineral density disesases using calcitonin and DHEA (an androgen)

摘要

A pharmaceutical formulation and it's use comprising a calcitonin-like agent and a dehydroepiandrosterone (DHEA)- like agent for the preparation of a pharmaceutical composition for increasing an individual's bone mineral density (BMD) wherein said medicament is formulated to provide the calcitonin-like and DHEA-like agents in an amount effective to increase BMD, and wherein administration of said medicament potentiates any increase in BMD achieved by administration of a similar amount of a calcitonin-like agent alone.